Last reviewed · How we verify
Mifepristone Oral Tablet [Korlym] — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
Mifepristone Oral Tablet [Korlym] (Mifepristone Oral Tablet [Korlym]) — VA Office of Research and Development.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Mifepristone Oral Tablet [Korlym] TARGET | Mifepristone Oral Tablet [Korlym] | VA Office of Research and Development | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Mifepristone Oral Tablet [Korlym] CI watch — RSS
- Mifepristone Oral Tablet [Korlym] CI watch — Atom
- Mifepristone Oral Tablet [Korlym] CI watch — JSON
- Mifepristone Oral Tablet [Korlym] alone — RSS
Cite this brief
Drug Landscape (2026). Mifepristone Oral Tablet [Korlym] — Competitive Intelligence Brief. https://druglandscape.com/ci/mifepristone-oral-tablet-korlym. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab